Invited Lectures
• Cambridge Health Institute, Multidrug Resistance in Cancer, San Francisco, CA (1993)
• Minisymposium, American Association for Cancer Research, San Francisco, USA (1994)
• 1st International Conference on Reversal of Multidrug Resistance in Cancer, St. Gallen, Switzerland (1994)
• XVI International Cancer Congress, New Delhi, India (1994)
• IBC, Multidrug Resistance in Cancer, Bethesda, MD (1995)
• Symposium on Clinical Involvement of Multidrug Resistance in Cancer, University of Quebec, Montreal, Canada (1995)
• International Meeting on Drug Resistance in Cancer, Dublin City University, Ireland (1995)
• FEBS Advanced Lecture Course, “ATP Binding Cassette (ABC) Transporters: From Multidrug Resistance to Genetic Disease”, Gosau, Austria (1997)
• 2nd Canadian MDR Meeting, Toronto, Canada. (1997)
• Research Grand Rounds, H. Lee Moffitt Cancer Center & Research Institute, Tempa Florida, (1998)
• EORTC - European Organization for Research and Treatment of Cancer, Winter Meeting, Nancy France, (1998)
• Controversy Session American Association for Cancer Research, New Orleans, USA, (1998)
• Minisymposium, American Association for Cancer Research, New Orleans, USA, (1998)
• IMSUT Forum for Genome Medicine, Tokyo, Japan, (1999)
• 31st Annual meeting of the European Society of Human Genetics, Geneva, Switzerland, (1999)
• Bio ’99 International Biotechnology Meeting & Exhibition, Seattle, WA, USA, (1999)
• Cancer Institute of New Jersey Translational Research Seminar, New Jersey, USA, (1999)
• Organizer and speaker, Novartis Foundation 50th Anniversary Symposium on ‘From Genome to Therapy: Integrating New Technologies With Drug Development’, Basel, Switzerland, (1999)
• 10 International Congress on Genes, Gene Families, and Isozymes, Functional Genomics: From Genes to New Therapies, Beijing, China, (1999)
• Chair and speaker, The Second China-Novartis Minisymposium, Beijing, China, (1999)
• GenomeX 2000: The European Forum for Genomics Business & Technology, Munich, Germany, (2000)
• Strategic Planning for Functional Genomics, Café Royal, London, (2001)
• UMDNJ-RWJMS Molecular Genetics and Microbiology, NJ, (2001)
• Genomics Conference, JPMorgan H&Q, Boston, (2001)
• Symposium on the New Frontier of Drug Discovery Science, Tokyo, Japan, (2001)
• Tokyo University, Japan, (2001)
• Tokyo Institute of Technology, Japan, (2001)
• Genomics and Proteomics, Marcusevans Conference, Switzerland, (2002)
• Albert Einstein College of Medicine, Dept. of Molecular Pharmacology HDACs & Cancer (2002)
• Japanese Society of Toxicology, Functional Genomics and Drug Discovery. Tokyo (2002)
• Genomics on Target, From Function to Validation, Boston, Massachusetts (2002)
• Proposer and speaker, Novartis Foundation Symposium No. 259 on ‘Reversible Acetylation of Chromatin and Non-Histone Proteins: Biology and Relevance to Human Disease’, London, UK (2003)
• Genome Tri-Conference, Leveraging Functional Genomics Technologies to Meet the Needs of the Pharmaceutical Industry, Santa Clara, CA (2003)
• SAPA 6th Annual Conference, Drug Discovery and Life Science 2003, Boston, MA (2003)
• Genomics on Target Conference, Functional Genomics, Boston, MA (2003)
• Chips to Hits Conference, IBC Life Sciences 2003, Boston, MA (2003)
• World Drug Discovery & Development Summit, World Trade Company, Copenhagen, Denmark (2004)
• R&D Leaders Forum, Phacilitate Limited, Coral Gables, Florida, (2004)
• Drug Discovery & Technology Leaders Summit, Oxford International, Orlando, Florida, (2004)
• The Global Translation of Science into Drug Development in Advancing Therapy, 2nd Pharmaceutical Sciences World Congress, Kyoto, Japan (2004)
• Molecular Targets For Cancer Therapy. H. Lee Moffitt Cancer Center, Florida (2004)
• Current trends in Pharmaceutical Sciences: Role of Genomics and Proteomics. The Ramanbhai Foundation Ahmedabad, India (2005)
• Drugs In the Postgenomics Era
• ETH, Swiss Federal Institute of Technology Zurich Switzerland (2005)
• Proteomics & Bioinformatics , Keystone Conference, Keystone Colorado ( 2005)
• University of Geneva, Geneva Switzerland (2005)
• SBS 11th Annual Conference & Exhibition, Geneva (September 2005)
• International symposium on translational research: apoptosis & cancer. Trivandrum, India, (2005)
• CHI, microRNA in human diseases. Boston (March 2006)
• CHI , Tri Molecular conference
• CHI, Tri Molecular Conference (March 2008)
• Bio 2008 (June 2008)
• Rockefeller University (Feb. 2009)
• Albert Einstein College of Medicine (Feb. 2009)
• EDRN,Lung/Upper Aerodigestive Cancers, Collaborative Group (March 2009)
• Panelist at Bio2009, Atlanta (May 2009)
• Bio Business Asia Taipei (July 2009)
• Tri Molecular conference San Francisco (Feb. 2010)
• Fondazione Pezcoller Trento Italy (June 2010)
• Computational Biology, Basel, Switzerland (June 2010)
• Molecular Diagnostics Europe, Hanover Germany (October 2011)